Int Arch Cardiovasc Dis 2018
DOI: 10.23937/iacvd-2017/1710013
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Significance and Applications of D-Ribose in Cardiovascular Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 25 publications
0
1
0
Order By: Relevance
“…By elongating load duration or changing load type, it is expected that the engineered collagenous tissue properties as demonstrated in this study can be further manipulated 17,19,42,45,71 . To stretch the boundaries of our current approach, additives like TGF β 79 , ribose 80,81 , copper 82 or beta-aminopropionitrile 83 might be added, to further stimulate collagen deposition, induce AGE related crosslinking and enhance or inhibit LOX catalyzed crosslinking respectively. Lastly, plaque and cap rupture cannot be attributed to solely suboptimal collagenous properties.…”
Section: Discussionmentioning
confidence: 99%
“…By elongating load duration or changing load type, it is expected that the engineered collagenous tissue properties as demonstrated in this study can be further manipulated 17,19,42,45,71 . To stretch the boundaries of our current approach, additives like TGF β 79 , ribose 80,81 , copper 82 or beta-aminopropionitrile 83 might be added, to further stimulate collagen deposition, induce AGE related crosslinking and enhance or inhibit LOX catalyzed crosslinking respectively. Lastly, plaque and cap rupture cannot be attributed to solely suboptimal collagenous properties.…”
Section: Discussionmentioning
confidence: 99%